Clinical Trials on Lipomatosis, Multiple Symmetrical
Total 8619 results
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Bristol-Myers SquibbTerminated
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Cantonal Hospital of St. GallenCompletedMultiple Sclerosis, Relapsing Remitting
-
Bayhill TherapeuticsCompletedRelapsing Remitting Multiple Sclerosis
-
Boston Children's HospitalRecruitingExtracorporeal Membrane Oxygenation | Red Blood Cell Transfusion | Organ Failure, MultipleUnited States, Canada, Australia
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
Galapagos NVTerminatedClinically Isolated Syndrome | Acute Exacerbation of Remitting Relapsing Multiple SclerosisBelgium, Poland, Germany
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Conditions, MultipleUnited States
-
Innovation Research & TrainingCompletedHealthy | Chronic Illnesses, MultipleUnited States
-
Shirley Ryan AbilityLabNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple SclerosisIran, Islamic Republic of
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
Assaf-Harofeh Medical CenterUnknownRemoval of Colors Tattoo (Multiple Colors)Israel
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
Johns Hopkins UniversityCompletedProgressive Multiple SclerosisUnited States
-
SanofiCompletedProgressive Multiple SclerosisGermany
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
Indiana UniversityUniversity of Alabama at Birmingham; University of OttawaCompletedProgressive Multiple SclerosisUnited States
-
Nantes University HospitalCompletedProgressive Multiple SclerosisFrance
-
University of CalgaryCompletedMultiple Sclerosis, Primary ProgressiveCanada
-
National Institute of Allergy and Infectious Diseases...CompletedMultiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
Mansoura University HospitalUnknownMultiple Sclerosis | Sexual DysfunctionEgypt
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
Universitätsklinikum Hamburg-EppendorfDeutsche Multiple Sklerose Gesellschaft HamburgUnknown
-
MedDay Pharmaceuticals SAUnknown
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisGermany